Stock listing
OTC:AMBIQ Ambipar Emergency Response Stock
Follow Ambipar Emergency Response into a list and get an email when it puts out news.
Share price · OTC:AMBIQ
$0.07 USD 0.00 (0.0%)
Close on Nov 18, 2026 · Data provided by Twelve Data
- Day range
- $0.07 – $0.07 USDNov 18, 2026
- Market cap
- —Left out: too few shares trade to back it
- Traded on an average day
- $29 USDMedian day 0 shares · 33 days with no trades · last 3 months, Oct 2, 2026 – Nov 18, 2026

Daily closes
Last 3 months, Oct 2, 2026 – Nov 18, 2026 · OTC:AMBIQ · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | 0.00 | 0.0% | $0.07 | $0.07 | $0.07 | 0 | |
| $0.07 | — | — | $0.07 | $0.07 | $0.07 | 14,142 |
- Ticker
- OTC:AMBIQ
- Asset type
- Stock
- Sector
- Industrials
- Industry
- Waste & environmental services
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest deck · Jul 9, 2026
Investor Presentation (July 2026)
Investor deck · 51 slides
Ambipar Emergency Response on 6ix
- Sector
- Industrials
- Industry
- Waste & environmental services
- Decks
- 4 decks · latest Jul 9, 2026
Valuation
price Nov 18, 2026
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 0.24
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (July 2026) | Investor deck | 51 slides | Jul 9, 2026 |
| Q2 2024 Earnings Presentation | Earnings | 21 slides | Aug 9, 2024 |
| Investor Day (May 2024) | Investor day | 47 slides | May 30, 2024 |
| Investor Presentation (October 2023) | Investor deck | 23 slides | Oct 10, 2023 |
Financials
Annual, in BRL
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 3.25B | 2.59B | 1.68B | 822.2M | 364.3M |
| Cost of revenue | 2.77B | 2.09B | 1.34B | 618.7M | 256.1M |
| Gross profit | 478.8M | 499.5M | 347.1M | 203.5M | 108.1M |
| Selling, general and administrative | 32.3M | 28.4M | 26.6M | 26.8M | 19.0M |
| Operating income | 485.8M | 360.4M | 336.8M | 178.0M | 89.9M |
| Interest expense | 592.9M | 294.8M | 113.5M | 12.8M | 14.5M |
| Income before tax | 126.8M | 109.0M | 232.8M | 176.0M | 82.8M |
| Income tax | -68.0M | -91.9M | -44.9M | -37.9M | 16.8M |
| Net income | -20.6M | -62.5M | 161.5M | 131.1M | 61.7M |
| Earnings per share, basic | 1.06 | 0.19 | 0.72 | 2.84 | 1.79 |
| Earnings per share, diluted | 0.82 | 0.17 | 0.72 | 2.84 | 1.79 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash and equivalents | 358.4M | 423.3M | 271.6M | 118.9M | 61.8M |
| Receivables | 1.10B | 803.5M | 703.0M | 234.3M | |
| Inventory | 46.3M | 34.2M | 18.1M | 8.78M | |
| Current assets | 1.75B | 1.44B | 1.13B | 453.4M | |
| Property, plant and equipment | 979.3M | 787.6M | 516.1M | 296.4M | |
| Goodwill | 1.80B | 1.54B | 1.19B | 585.7M | |
| Total assets | 5.80B | 4.31B | 3.43B | 1.43B | |
| Accounts payable | 218.2M | 184.6M | 146.6M | 39.6M | |
| Current liabilities | 978.5M | 803.0M | 717.0M | 346.1M | |
| Long-term debt | 778.0M | 617.5M | 649.8M | 94.5M | |
| Total debt | 1.45B | 1.25B | 1.32B | 187.0M | |
| Total liabilities | 2.95B | 2.98B | |||
| Shareholders' equity | 1.45B | 1.07B | 365.4M | 326.0M | 327.2M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Cash from operations | 421.4M | 78.5M | 470.9M | 64.3M | 32.5M |
| Cash from investing | -134.7M | -287.4M | -1.32B | -448.4M | -117.7M |
| Cash from financing | -514.1M | 417.3M | 994.7M | 433.2M | 108.9M |
| Dividends paid | -51.7M | -31.9M | 0 | -63.0K | |
| Change in cash | -227.5M | 208.3M | 144.9M | 49.2M | 23.7M |
Cap table
Built by 6ix from Ambipar Emergency Response’s releases
- Common shares
- 16,195,105
- Fully diluted
- 16,195,105
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 16,195,105 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 16,195,105 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| David J Mack Other companies: BioXcel Therapeutics, Inc. (Director · Since at least Nov 21, 2024) | Director · Since at least Mar 18, 2026 |
| Alessandra Bessa Alves de Melo | Director · Since at least Mar 17, 2026 |
| Guilherme Patini Borlenghi | Director · Since at least Mar 17, 2026 |
| Marco Antonio Zanini | Director · Since at least Mar 17, 2026 |
| Ricardo Chagas | CEO and CFO · Since at least Mar 17, 2026 |
| Tercio Junior Borlenghi | Director · Since at least Mar 17, 2026 |
| Thiago da Costa Silva | Director · Since at least Mar 17, 2026 |
Log in to ask 6ix AI your own questions about Ambipar Emergency Response.